aCardiogenic shock (CS) is part of a clinical syndrome consisting of acute left ventricular failure causing severe hypotension leading to inadequate organ and tissue perfusion. The most commonly used devices to support patients affected by CS are Intra-Aortic Balloon Pump (IABP), Impella 2.5 pump and Extracorporeal Membrane Oxygenation. The aim of this study is the comparison between Impella and IABP using CARDIOSIM (c) software simulator of the cardiovascular system. The results of the simulations included baseline conditions from a virtual patient in CS followed by IABP assistance in synchronised mode with different driving and vacuum pressures. Subsequently, the same baseline conditions were supported by the Impella 2.5 with different rotational speeds. The percentage variation with respect to baseline conditions was calculated for haemodynamic and energetic variables during IABP and Impella assistance. The Impella pump driven with a rotational speed of 50,000 rpm increased the total flow by 4.36% with a reduction in left ventricular end-diastolic olume (LVEDV) byl congruent to 15% to congruent to= 30%. A lreduction in left ventricular end systolic volume (LVESV) by congruent to 10% to congruent to 18% (congruent to 12% to congruent to = 33%) was observed with IABP (Impella) assistance. The simulation outcome suggests that assistance with the Impella device leads to higher reduction in LVESV, LVEDV, left ventricular external work and left atrial pressure-

IABP versus impella support in cardiogenic shock. “in silico” study / De Lazzari, Beatrice; Capoccia, Massimo; Badagliacca, Roberto; Bozkurt, Selim; De Lazzari, Claudio. - In: JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE. - ISSN 2308-3425. - 10:4(2023). [10.3390/jcdd10040140]

IABP versus impella support in cardiogenic shock. “in silico” study

Badagliacca, Roberto
;
De Lazzari, Claudio
2023

Abstract

aCardiogenic shock (CS) is part of a clinical syndrome consisting of acute left ventricular failure causing severe hypotension leading to inadequate organ and tissue perfusion. The most commonly used devices to support patients affected by CS are Intra-Aortic Balloon Pump (IABP), Impella 2.5 pump and Extracorporeal Membrane Oxygenation. The aim of this study is the comparison between Impella and IABP using CARDIOSIM (c) software simulator of the cardiovascular system. The results of the simulations included baseline conditions from a virtual patient in CS followed by IABP assistance in synchronised mode with different driving and vacuum pressures. Subsequently, the same baseline conditions were supported by the Impella 2.5 with different rotational speeds. The percentage variation with respect to baseline conditions was calculated for haemodynamic and energetic variables during IABP and Impella assistance. The Impella pump driven with a rotational speed of 50,000 rpm increased the total flow by 4.36% with a reduction in left ventricular end-diastolic olume (LVEDV) byl congruent to 15% to congruent to= 30%. A lreduction in left ventricular end systolic volume (LVESV) by congruent to 10% to congruent to 18% (congruent to 12% to congruent to = 33%) was observed with IABP (Impella) assistance. The simulation outcome suggests that assistance with the Impella device leads to higher reduction in LVESV, LVEDV, left ventricular external work and left atrial pressure-
2023
CARDIOSIM©; IABP; Impella; cardiogenic shock; cardiovascular modelling; chronic heart failure; lumped parameter model; software simulation; ventricular elastance
01 Pubblicazione su rivista::01a Articolo in rivista
IABP versus impella support in cardiogenic shock. “in silico” study / De Lazzari, Beatrice; Capoccia, Massimo; Badagliacca, Roberto; Bozkurt, Selim; De Lazzari, Claudio. - In: JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE. - ISSN 2308-3425. - 10:4(2023). [10.3390/jcdd10040140]
File allegati a questo prodotto
File Dimensione Formato  
DeLazzari_IABP_2023.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 4.3 MB
Formato Adobe PDF
4.3 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1705691
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact